Loading...
Market
Number of Violations to Synthetic DNA Regulations by 2024
5
Resolution / Starting Odds
No Violations • 25%
Few Violations (1-10) • 25%
Several Violations (11-50) • 25%
Many Violations (More than 50) • 25%
Government regulatory bodies' official reports
Story
U.S. White House Policy Tightens Regulation on Synthetic DNA
May 8, 2024, 08:43 AM
The U.S. government is intensifying its efforts to regulate synthetic DNA, a move supported by industry leaders and biosecurity experts. A new White House policy aims to standardize the screening processes across companies like Twist Bioscience that produce and distribute synthetic DNA. This initiative seeks to prevent misuse by ensuring that providers verify both the sequences ordered and the credentials of those ordering them. Emily Leproust of Twist Bioscience welcomed the policy, emphasizing the ethical responsibility in promoting responsible research and rigorous screening of synthetic DNA.
View original story
Similar markets
High adoption by healthcare sector • 25%
High adoption by agricultural sector • 25%
Low adoption by healthcare sector • 25%
Low adoption by agricultural sector • 25%
Highly effective • 33%
Moderately effective • 33%
Not effective • 33%
0-5 companies • 25%
6-10 companies • 25%
11-15 companies • 25%
More than 15 companies • 25%
0-5 cases • 25%
6-10 cases • 25%
11-20 cases • 25%
More than 20 cases • 25%
Less than 5 • 25%
5-10 • 25%
11-15 • 25%
More than 15 • 25%
None • 25%
1-5 companies • 25%
6-10 companies • 25%
More than 10 companies • 25%
Increase in violations • 33%
Decrease in violations • 33%
No significant change • 34%
Full compliance • 33%
Partial compliance • 33%
Non-compliance • 34%
Less than 50% • 25%
50% - 74% • 25%
75% - 89% • 25%
90% or more • 25%
High compliance • 33%
Moderate compliance • 34%
Low compliance • 33%
Full compliance • 33%
Partial compliance • 33%
No compliance • 34%